92406-41-2 Usage
Description
1H-Pyrazol-5-amine, 3-cyclobutyl-1-methylis a chemical compound with the molecular formula C8H12N4. It is a derivative of pyrazole, a six-membered aromatic heterocyclic compound containing two nitrogen atoms at positions 1 and 3. The addition of a cyclobutyl group and a methyl group to the 3-position of the pyrazole ring gives rise to the unique properties of this compound. It is commonly used in pharmaceutical research and development, specifically in the synthesis of potential drug candidates due to its diverse pharmacological activities. Additionally, it has been studied for its potential anti-inflammatory and analgesic properties. Overall, 1H-Pyrazol-5-amine, 3-cyclobutyl-1-methylis a valuable compound with potential applications in the pharmaceutical industry.
Uses
Used in Pharmaceutical Research and Development:
1H-Pyrazol-5-amine, 3-cyclobutyl-1-methylis used as a building block for the synthesis of potential drug candidates due to its diverse pharmacological activities.
Used in Anti-inflammatory and Analgesic Applications:
1H-Pyrazol-5-amine, 3-cyclobutyl-1-methylis used as a potential anti-inflammatory and analgesic agent, as it has been studied for its potential to exhibit these properties.
Check Digit Verification of cas no
The CAS Registry Mumber 92406-41-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,4,0 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 92406-41:
(7*9)+(6*2)+(5*4)+(4*0)+(3*6)+(2*4)+(1*1)=122
122 % 10 = 2
So 92406-41-2 is a valid CAS Registry Number.
92406-41-2Relevant articles and documents
9H-PYRIMIDO[4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS
-
Paragraph 0617-0618, (2015/09/28)
The present disclosure provides substituted 9H-pyrimido[4,5-b]indoles and 5H-pyrido[4,3-b]indoles and related analogs represented by Formula I: and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein R1a, A, B1, B2, G, X1, Y1, Y2, and Y3 are as defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to treat a condition or disorder responsive to inhibition of BET bromodomains. Compounds of the present disclosure are especially useful for treating cancer.
Studies on dihydropyridines. II. Synthesis of 4,7-dihydropyrazolo[3,4-b]pyridines with vasodilating antihypertensive activities
Adachi,Yamamori,Hiramatsu,Sakai,Sato,Kawakami,Uno,Ueda
, p. 3235 - 3252 (2007/10/02)
-
